UCLA Jonsson Comprehensive Cancer Center | Strategic Alliance Partners

Latest from UCLA Jonsson Comprehensive Cancer Center


Shaping a New Future With Novel Therapeutics in Gynecologic Cancers

October 31, 2020

Ritu Salani, MD, MBA, discusses updates to PARP inhibition and FRα-targeting agents in ovarian cancer, the role of bevacizumab across all lines of ovarian cancer therapy, and immunotherapy highlights in cervical and endometrial cancer.

x